Discontinuation report STAXYN
| Report ID | 163103 |
| Drug Identification Number | 02372436 |
| Brand name | STAXYN |
| Common or Proper name | VARDENAFIL |
| Company Name | BAYER INC |
| Market Status | MARKETED |
| Active Ingredient(s) | VARDENAFIL |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
| Route of administration | ORAL ORAL |
| Packaging size | 4's |
| ATC code | G04BE |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2022-06-30 |
| Actual discontinuation date | |
| Remaining supply date | 2018-11-13 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
| Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2022-06-20 | English | Compare |
| v2 | 2022-06-20 | French | Compare |
Showing 1 to 2 of 2